HORSHAM, PA / ACCESS Newswire / October 7, 2026 / Surmodics, a provider of surface technologies and performance coatings for the medical device industry, today announced at the opening of the American ...
Surmodics buys Alta Biomed to expand its surface technology portfolio with PzF thin-film coatings for cardiovascular and ...
The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzFâ„¢ thin-film surface ...
Surmodics Inc. (NASDAQ:SRDX) shares soared 50% on Tuesday after a U.S. District Court denied the Federal Trade Commission’s (FTC) motion for a preliminary injunction that sought to halt the company’s ...
Surmodics has acquired the business of Alta Biomed, expanding its portfolio of hemocompatible and biocompatible surface ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered ...
Surmodics has a lot riding on the FDA's decision: Under the terms of a 2018 deal giving Abbott commercialization rights, the company could collect a multimillion-dollar milestone payment once it's ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ: SRDX), the global leader in medical device coating technologies, announced the commercial launch of its most advanced hydrophilic medical ...
Surmodics makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests. On Wednesday morning, before the markets opened, the healthcare company announced that the FDA ...
Acquisition adds proven PzF thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility HORSHAM, PA / ACCESS Newswire / Octob ...
Surmodics, Inc. SRDX has been gaining on the back of its solid prospects in the thrombectomy business over the past few months. A robust third-quarter fiscal 2022 performance and consistent efforts to ...